LTB4-BLT1 Interactions in the Pathogenesis of Allergic Airway Disease

LTB4-BLT1 相互作用在过敏性气道疾病发病机制中的作用

基本信息

  • 批准号:
    7255194
  • 负责人:
  • 金额:
    $ 58.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

The pathophysiology of asthma is complex with several pathways capable of mediating airway hyperresponsiveness (AHR), airway inflammation, and goblet cell metaplasia. Moreover, the contributors to the initiation/sensitization phase of the disease may differ considerably from the factors responsible for the challenge/maintenance/progression phase. Because of the difficulties in studying and dissecting these phases and their underlying pathophysiology in asthmatics, animal models have proven invaluable in this regard. Despite some limitations, mouse models have provided important insights into the pathophysiology of (human) asthma, especially when different approaches to allergen exposure have been used to identify specific mast cell-lgE-dependent and mast cell-independent pathways which elicit similar phenotypes. The central hypothesis of this project is that a novel and unique subset of CD8+ T cells plays an important role in the development of altered airway function, lung inflammation, and goblet cell metaplasia, with IL-13 being the critical mediator of these responses. We posit that this subset of CD8+ T cells is essential due to their ability to produce IL-13. The key feature in their recruitment (andactivation) in the lung is their expression of BLT1, a high affinity receptor for leukotriene B4 (LTB4). LTB4 is postulated to be released from activated mast cells and macrophages in allergen-exposed allergic hosts. Based on extensive preliminary data, we have placed this unique subset of CD8+BLT1+IL-13+ T cells at the core of allergic responses in the lung. Using combinations of molecular, cellular, and biologic tools we will define the distribution and regulation of BLT1 expression on immune/inflammatory cells in the allergic lung, the consequences of LTB4 ligation of BLT1, the specific role of BLT1on T cell subsets, and their interactions in the development of AHR and lung inflammation as well as identifying the sources of LTB4 in allergen-exposed mice. In the last specific aim, we will translate these findings in allergic mice to clinical studies of asthmatics, defining the role of this unique, pathogenic subset of CD8+BLT1+IL-13+ T cells, which we demonstrated in BAL and lung tissue, determining whether they are increased in numbers in corticosteroid-resistant asthmatics and whether inhibition of LTB4 production leads to lower numbers of these cells in the airways and improved lung function in this subset of asthmatics. This project will provide novel insights into the pathogenesis and heterogeneity of asthma and provides a critical link to the two other projects in this program grant.
哮喘的病理生理是复杂的,有几种途径能够介导气道

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERWIN William GELFAND其他文献

ERWIN William GELFAND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERWIN William GELFAND', 18)}}的其他基金

LTB4-BLT1 Interactions in the Pathogenesis of Allergic Airway Disease
LTB4-BLT1 相互作用在过敏性气道疾病发病机制中的作用
  • 批准号:
    8147497
  • 财政年份:
    2010
  • 资助金额:
    $ 58.24万
  • 项目类别:
Administrative Core A
行政核心A
  • 批准号:
    8147505
  • 财政年份:
    2010
  • 资助金额:
    $ 58.24万
  • 项目类别:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
天然存在的 T 调节细胞控制气道高反应性
  • 批准号:
    7910663
  • 财政年份:
    2009
  • 资助金额:
    $ 58.24万
  • 项目类别:
Antenatal Dietary Supplementation is a Risk Factor for Infant Atopy Through Epige
Epige 发现产前膳食补充剂是婴儿特应性的危险因素
  • 批准号:
    7821778
  • 财政年份:
    2009
  • 资助金额:
    $ 58.24万
  • 项目类别:
Antenatal Dietary Supplementation is a Risk Factor for Infant Atopy Through Epige
Epige 发现产前膳食补充剂是婴儿特应性的危险因素
  • 批准号:
    7942064
  • 财政年份:
    2009
  • 资助金额:
    $ 58.24万
  • 项目类别:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
天然存在的 T 调节细胞控制气道高反应性
  • 批准号:
    7729164
  • 财政年份:
    2009
  • 资助金额:
    $ 58.24万
  • 项目类别:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
天然存在的 T 调节细胞控制气道高反应性
  • 批准号:
    8310977
  • 财政年份:
    2009
  • 资助金额:
    $ 58.24万
  • 项目类别:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
天然存在的 T 调节细胞控制气道高反应性
  • 批准号:
    8503580
  • 财政年份:
    2009
  • 资助金额:
    $ 58.24万
  • 项目类别:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
天然存在的 T 调节细胞控制气道高反应性
  • 批准号:
    8085839
  • 财政年份:
    2009
  • 资助金额:
    $ 58.24万
  • 项目类别:
Naturally occurring T regulatory cells control airway hyperresponsiveness
天然存在的 T 调节细胞控制气道高反应性
  • 批准号:
    7683378
  • 财政年份:
    2008
  • 资助金额:
    $ 58.24万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 58.24万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了